Partner Status Moderates the Relationships Between Sexual Problems and Self-efficacy for Managing Sexual Problems and Psychosocial Quality-of-life for Postmenopausal Breast Cancer Survivors Taking Adjuvant Endocrine Therapy
Overview
Authors
Affiliations
Objective: Past studies indicate that >90% of breast cancer survivors taking adjuvant endocrine therapy (AET) experience menopausal symptoms including sexual problems (eg, vaginal dryness, dyspareunia); however, research examining the impact of these problems on quality-of-life is limited. This cross-sectional study examined (1) the impact of sexual problems and self-efficacy for coping with sexual problems (sexual self-efficacy) on quality-of-life (ie, psychosocial quality-of-life and sexual satisfaction), and (2) partner status as a moderator of these relationships.
Methods: Postmenopausal breast cancer survivors taking AET completed measures of sexual problems (Menopause-Specific Quality-of-Life [MENQOL] sexual subscale], sexual self-efficacy, psychosocial quality-of-life (MENQOL psychosocial subscale), and sexual satisfaction (Functional Assessment of Cancer Therapy-General item).
Results: Bivariate analyses showed that women reporting greater sexual problems and lower sexual self-efficacy had poorer quality-of-life and less sexual satisfaction (all P-values < 0.05). Partner status moderated the relationship between sexual problems and psychosocial quality-of-life (P = 0.02); at high levels of sexual problems, unpartnered women experienced poorer psychosocial quality-of-life than partnered women. Partner status also moderated the relationship between self-efficacy and psychosocial quality-of-life (P = 0.01). Self-efficacy was unrelated to psychosocial quality-of-life for partnered women; for unpartnered women, low self-efficacy was associated with poorer quality-of-life. Partner status did not moderate the relationships between sexual problems or self-efficacy with sexual satisfaction.
Conclusions: Greater sexual problems and lower sexual self-efficacy were associated with poorer psychosocial quality-of-life and sexual satisfaction among postmenopausal breast cancer survivors taking AET. Interventions to address sexual problems and sexual self-efficacy, particularly among unpartnered women, may be beneficial for improving the well-being of postmenopausal breast cancer survivors on AET.
Nimbi F, Galizia R, Ciocca G, Bratina Zimic A, Jannini E, Simonelli C Int J Impot Res. 2024; .
PMID: 38926631 DOI: 10.1038/s41443-024-00942-2.
Tian Z, Xiaolu Z, Jing Y, Min W, Jiaqian L, Shouli C BMC Womens Health. 2024; 24(1):352.
PMID: 38890676 PMC: 11184704. DOI: 10.1186/s12905-024-03150-8.
Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review.
Claes M, Tuts L, Robijns J, Mulders K, Van De Werf E, Bulens P J Cancer Surviv. 2024; .
PMID: 38383907 DOI: 10.1007/s11764-024-01553-y.
Clinical Practice Strategies to Address Sexual Health in Female Cancer Survivors.
Arring N, Barton D, Reese J J Clin Oncol. 2023; 41(31):4927-4936.
PMID: 37535889 PMC: 10617876. DOI: 10.1200/JCO.23.00523.
Nowosielski K, Palka A Contemp Oncol (Pozn). 2023; 27(1):47-56.
PMID: 37266338 PMC: 10230241. DOI: 10.5114/wo.2023.127308.